Tim Demuth's most recent trade in Pieris Pharmaceuticals Inc was a trade of 6,000 Common Stock done at an average price of $1.7 . Disclosure was reported to the exchange on May 13, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Pieris Pharmaceuticals Inc | Tim Demuth | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.71 per share. | 13 May 2022 | 6,000 | 6,000 (0%) | 0% | 1.7 | 10,260 | Common Stock |
Pieris Pharmaceuticals Inc | Tim Demuth | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to buy) | |
Pieris Pharmaceuticals Inc | Tim Demuth | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2021 | 360,000 | 360,000 | - | - | Stock Option (right to buy) |